NCT02940496 2025-07-15Pembrolizumab (MK-3475) in Hepatocellular CarcinomaM.D. Anderson Cancer CenterPhase 2 Completed15 enrolled 8 charts
NCT03534141 2025-05-16MHALTUniversity of California, San FranciscoPhase NA Terminated175 enrolled 19 charts